- Home
- SMAR vs PEN Comparison
SMAR vs PEN Comparison
Compare SMAR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMAR
- PEN
- Stock Information
- Founded
- SMAR 2005
- PEN 2004
- Country
- SMAR United States
- PEN United States
- Employees
- SMAR N/A
- PEN N/A
- Industry
- SMAR Computer Software: Prepackaged Software
- PEN Medical/Dental Instruments
- Sector
- SMAR Technology
- PEN Health Care
- Exchange
- SMAR Nasdaq
- PEN Nasdaq
- Market Cap
- SMAR 7.9B
- PEN 9.1B
- IPO Year
- SMAR 2018
- PEN 2015
- Fundamental
- Price
- SMAR $56.46
- PEN $263.61
- Analyst Decision
- SMAR Hold
- PEN Buy
- Analyst Count
- SMAR 23
- PEN 15
- Target Price
- SMAR $55.28
- PEN $259.86
- AVG Volume (30 Days)
- SMAR 3.4M
- PEN 437.3K
- Earning Date
- SMAR 03-13-2025
- PEN 02-20-2025
- Dividend Yield
- SMAR N/A
- PEN N/A
- EPS Growth
- SMAR N/A
- PEN N/A
- EPS
- SMAR N/A
- PEN 0.89
- Revenue
- SMAR $1,083,216,000.00
- PEN $1,163,776,000.00
- Revenue This Year
- SMAR $19.27
- PEN $13.55
- Revenue Next Year
- SMAR $15.14
- PEN $14.48
- P/E Ratio
- SMAR N/A
- PEN $297.79
- Revenue Growth
- SMAR 18.55
- PEN 16.96
- 52 Week Low
- SMAR $35.52
- PEN $148.00
- 52 Week High
- SMAR $56.55
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- SMAR 69.59
- PEN 65.58
- Support Level
- SMAR $55.96
- PEN $237.65
- Resistance Level
- SMAR $56.43
- PEN $260.88
- Average True Range (ATR)
- SMAR 0.10
- PEN 9.66
- MACD
- SMAR 0.02
- PEN 1.91
- Stochastic Oscillator
- SMAR 96.15
- PEN 98.61
About SMAR Smartsheet Inc.
Smartsheet is a provider of collaborative work management software delivered via a cloud-based, software-as-a-service model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases. Smartsheet's offering supports workflow management across teams, provides real-time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per-user basis, and incremental charges for added platform capabilities.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.